1:1:1
Rapid evolution: From digitized to agentified in two years
What does it mean to make meaningful change? More than a decade ago, Medable was founded on a simple premise: bringing treatments to patients faster. What we encountered when we first started was an industry relatively moving at a fixed pace, approving only about 50 new treatments a year on average. This average remained constant since the year 2000, no matter how much R&D investment and new technology got poured in.
As the decade progressed and we developed our data platform, eCOA, eConsent, and Televisit tools, a vision began to take shape. This vision was a series of ambitious goals that we believe we can achieve within our lifetimes: our 1:1:1 vision.
More importantly, we’ve made meaningful, measurable, tested progress towards radically redefining how fast clinical trials can move, and how they can be made easier for every stakeholder involved in them. This rapid evolution of Medable and the industry has been meaningful, with clients in top-10 pharma deploying our latest technologies, helping us take major steps towards accomplishing our 1:1:1 vision.